Juvenile Diabetes

A Finnish study confirms the hypothesis that infant feeding plays a role in the initiation of the disease process leading to type 1 diabetes in children carrying increased genetic disease risk.

A research team has identified the role of a type of T cell in type 1 diabetes that may lead to new treatment options for young patients.

A study has found that obese adolescents with type 2 diabetes have diminished cognitive performance and subtle abnormalities in the brain as detected by Magnetic Resonance Imaging (MRI).

The results of the research offer the hope that, in future, it might be possible to encourage a newly diagnosed type 1 diabetes patient's own beta cells to reproduce as a means of replacing those being destroyed by the disease.

Researchers have provided the first evidence-based data on changes in drug metabolism in obese children as compared to healthy weight children.

Teenagers and tweenagers with type 1 diabetes have more trouble sticking to their treatment plan - thus raising their risk of blindness, kidney failure and heart disease - if their parents become increasingly lax about monitoring the child's treatment, or if the mother-child relationship is poor.

Early-stage human clinical trials showed that a new topical drug was safe and had biological effects in a type of diabetic eye disease, and may offer researchers a new approach to prevent and treat diabetic macular edema.

Using leptin alone in place of standard insulin therapy shows promise in abating symptoms of type 1 diabetes, UT Southwestern Medical Center researchers report.

A genetic variation in mitochondria, the energy-producing machinery of cells, prevents young obese subjects with diabetes type 2 to respond to physical exercise.

Study published in the American Journal of Preventive Medicine revealed that only about half of U.S. adults with prediabetes reported that in the past year they tried to lose weight or exercise more.

Researchers showed that using a first-generation artificial pancreas system overnight can lower the risk of low blood sugar emergencies while sleeping, and at the same time improve diabetes control.

Metformin XR appears to cause a small but significant decrease in body mass index (BMI) in non-diabetic obese adolescents when combined with a lifestyle intervention program.

Half of the mothers who took part in a study thought that their obese four or five year-old was normal weight, as did 39 per cent of the fathers.

Researchers found 13 new genetic variants that influence blood glucose regulation, insulin resistance, and the function of insulin-secreting beta cells in populations of European descent. Five of the variants increase the risk of developing type 2 diabetes.

Research review of the effects of Vitamins C and E and magnesium on diabetic retinopathy and findings from the first large study of vision problems in Hispanic and African-American infants and young children.

Due to a lack of suitable studies, it remains unclear whether children and adolescents with type 1 diabetes benefit more or less from long-term treatment with rapid-acting insulin analogues than with short-acting human insulin.